|
PRMT10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.1094237467878E-15 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.517800E-01 |
| Stage1-vs-Stage3 |
2.498600E-01 |
| Stage1-vs-Stage4 |
4.357000E-04 |
| Stage2-vs-Stage3 |
9.690200E-02 |
| Stage2-vs-Stage4 |
5.777600E-04 |
| Stage3-vs-Stage4 |
5.678100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.29040111929157E-11 |
| Normal-vs-Asian |
1.6242562850266E-12 |
| Caucasian-vs-AfricanAmerican |
9.344800E-01 |
| Caucasian-vs-Asian |
7.261000E-01 |
| AfricanAmerican-vs-Asian |
7.841600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.351400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.7754000000435E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.968800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.699200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.805000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.556000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.596800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.739400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.48269999999895E-05 |
| Classical-VS-Follicular |
9.806600E-04 |
| Classical-VS-Other |
8.705600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.22719999612531E-08 |
| Tall-VS-Other |
5.208300E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.269900E-02 |
| Follicular-VS-Normal |
3.84137166520304E-14 |
| Other-VS-Normal |
1.08840048085312E-10 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.226200E-02 |
|
|
